Drug
Who makes potassium phosphate, monobasic potassium phosphate, dibasic?
3 companies list potassium phosphate, monobasic potassium phosphate, dibasic as a human prescription drug. Forms: injection, solution; injection, solution, concentrate. Routes: intravenous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing potassium phosphate, monobasic potassium phosphate, dibasic
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Fresenius Kabi USA, LLCUnited States | injection, solution, concentrate | NDANDA212832 | 3 | 6 |
| American Regent, Inc.United States | injection, solution | ANDAANDA216274 | 1 | 5 |
| Civica, Inc. dba CivicaRxUnited States | injection, solution, concentrate | NDANDA212832 | 1 | 1 |
Enquiry
Common questions
- Who makes potassium phosphate, monobasic potassium phosphate, dibasic?
- 3 companies list potassium phosphate, monobasic potassium phosphate, dibasic as a human prescription drug in the openFDA NDC Directory, led by Fresenius Kabi USA, LLC, American Regent, Inc., Civica, Inc. dba CivicaRx. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic potassium phosphate, monobasic potassium phosphate, dibasic?
- 1 company lists potassium phosphate, monobasic potassium phosphate, dibasic under an abbreviated new drug application (ANDA), the application type used for generics, and 2 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.